Presentation is loading. Please wait.

Presentation is loading. Please wait.

(A) Energy and (B) protein intake/day during hospitalisation and in follow-up. (A) Energy and (B) protein intake/day during hospitalisation and in follow-up.

Published bySurya Yuwono Modified over 5 years ago

Similar presentations

Presentation on theme: "(A) Energy and (B) protein intake/day during hospitalisation and in follow-up. (A) Energy and (B) protein intake/day during hospitalisation and in follow-up."— Presentation transcript:

1 (A) Energy and (B) protein intake/day during hospitalisation and in follow-up.
(A) Energy and (B) protein intake/day during hospitalisation and in follow-up. Total energy and protein intake per kg actual body weight at baseline, during hospitalisation versus follow-up. ONS: 28 kcal v 39 kcal, p=0.002 and 1.2 g vs 1.4 g, p= Snacks: 32 kcal vs 40 kcal, p=0.009 and 1.4 g vs 1.8 g, p= ONS, oral nutritional supplements. Arora Ros Ingadottir et al. BMJ Open Resp Res 2019;6:e000349 ©2019 by British Thoracic Society

Download ppt "(A) Energy and (B) protein intake/day during hospitalisation and in follow-up. (A) Energy and (B) protein intake/day during hospitalisation and in follow-up."

Similar presentations

Vitamin D3 increased ASL antimicrobial activity.

Vitamin D3 increased ASL antimicrobial activity.
The significantly different metabolites between the systemic inflammatory response syndrome SIRS (n=15) and sepsis (n=35) groups (A); the sepsis (n=10)

The significantly different metabolites between the systemic inflammatory response syndrome SIRS (n=15) and sepsis (n=35) groups (A); the sepsis (n=10)
Association between average daily intake of alcoholic drinks and risk of active tuberculosis using restricted cubic spline regression with four knots*.

Association between average daily intake of alcoholic drinks and risk of active tuberculosis using restricted cubic spline regression with four knots*.
Mean changes in the Short Form-36 subscales from baseline values for combined pulmonary fibrosis and emphysema (CPFE) (n=16), and chronic obstructive pulmonary.

Mean changes in the Short Form-36 subscales from baseline values for combined pulmonary fibrosis and emphysema (CPFE) (n=16), and chronic obstructive pulmonary.
(A) Changes in plaque and gingival index (Silness and Löe)21 for patients 1–8 over a 7-day period using oral hygiene intervention either with a toothbrush.

(A) Changes in plaque and gingival index (Silness and Löe)21 for patients 1–8 over a 7-day period using oral hygiene intervention either with a toothbrush.
 Effects of nitrate ingestion (10 mg/kg body weight at 0 min) on (A) FENO values, (B) nitrite and (C) nitrate concentrations in oral (filled circles) and.

 Effects of nitrate ingestion (10 mg/kg body weight at 0 min) on (A) FENO values, (B) nitrite and (C) nitrate concentrations in oral (filled circles) and.
Patients with exacerbations of chronic obstructive pulmonary disease admitted to hospital according to the day of the week (A), and presenting to the emergency.

Patients with exacerbations of chronic obstructive pulmonary disease admitted to hospital according to the day of the week (A), and presenting to the emergency.
Vitamin D3 supplementation decreased the correlation of 25(OH)D3 to 1,25(OH)2D3. Vitamin D3 supplementation decreased the correlation of 25(OH)D3 to 1,25(OH)2D3.

Vitamin D3 supplementation decreased the correlation of 25(OH)D3 to 1,25(OH)2D3. Vitamin D3 supplementation decreased the correlation of 25(OH)D3 to 1,25(OH)2D3.
The top 25 analytes by relevant q-value differentially expressed in HIV with COPD. The top number is m/z and the bottom number is RT. Y-axis is intensity.

The top 25 analytes by relevant q-value differentially expressed in HIV with COPD. The top number is m/z and the bottom number is RT. Y-axis is intensity.
The excess effect of 3 or 6 months low to moderate carbohydrate diet compared with high-carbohydrate diet on HbA1c (%) versus reported intake (Energy %)

The excess effect of 3 or 6 months low to moderate carbohydrate diet compared with high-carbohydrate diet on HbA1c (%) versus reported intake (Energy %)
For most patients with asthma airway response becomes flatter after 1000 µg of inhaled corticosteroid, but systemic activity (measured by serum cortisol.

For most patients with asthma airway response becomes flatter after 1000 µg of inhaled corticosteroid, but systemic activity (measured by serum cortisol.
Variable life adjusted display (VLAD chart) showing observed versus expected mortability with cumulative lives lost below the x-axis and cumulative lives.

Variable life adjusted display (VLAD chart) showing observed versus expected mortability with cumulative lives lost below the x-axis and cumulative lives.
Association of sputum colour score with (A) total cell counts; (B) neutrophil proportion; (C) neutrophil number and (D) CXCL-8 concentration. Association.

Association of sputum colour score with (A) total cell counts; (B) neutrophil proportion; (C) neutrophil number and (D) CXCL-8 concentration. Association.
Modelled mean (SEM) observed forced vital capacity (FVC) volume change from baseline (mL) over time by dose intensity (>90%, ≤90%), based on actual dose.

Modelled mean (SEM) observed forced vital capacity (FVC) volume change from baseline (mL) over time by dose intensity (>90%, ≤90%), based on actual dose.
Serum levels of angiopoietin-like protein 4 (ANGPTL4) according to patients with chronic obstructive pulmonary disease and controls without any lung disease.

Serum levels of angiopoietin-like protein 4 (ANGPTL4) according to patients with chronic obstructive pulmonary disease and controls without any lung disease.
Serum levels of angiopoietin-like protein 4 according to (A) cardiac dysfunction (ie, abnormal N-terminal pro-B-type natriuretic peptide level) and (B)

Serum levels of angiopoietin-like protein 4 according to (A) cardiac dysfunction (ie, abnormal N-terminal pro-B-type natriuretic peptide level) and (B)
Change from baseline in (A) E-RS total score and (B) E-RS cough and sputum domain score over the study period in ATTAIN and the active-comparator study.

Change from baseline in (A) E-RS total score and (B) E-RS cough and sputum domain score over the study period in ATTAIN and the active-comparator study.
(A) Refined profile principal component analysis loading weights plot was used to derive insight into possible association of biomarkers. (A) Refined profile.

(A) Refined profile principal component analysis loading weights plot was used to derive insight into possible association of biomarkers. (A) Refined profile.
Percentage of patients per stage of oesophageal cancers in the two trials, overall difference P

Percentage of patients per stage of oesophageal cancers in the two trials, overall difference P
Change from baseline in the severity of night-time cough and the frequency of night-time sputum production at week 12 in ACCORD COPD I.17 Data are reported.

Change from baseline in the severity of night-time cough and the frequency of night-time sputum production at week 12 in ACCORD COPD I.17 Data are reported.

Similar presentations

Ads by Google